NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110064803A1
SERIAL NO

11569206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to compositions comprising a nanoparticulate vitamin K2 having improved bioavailability. The nanoparticulate vitamin K2 particles of the composition have an effective average particle size of less than about 2000 nm and are useful in the prevention and treatment of osteoporosis. The invention also relates to a controlled release composition comprising a vitamin K2 or a nanoparticulate vitamin K2 that in operation delivers the drug in a pulsed or multi-modal manner for the prevention and treatment of osteoporosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELAN PHARMA INTERNATIONAL LIMITEDTREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Devane, John G Barrymore Athlone, IE 27 1757
Fanning, Niall MN Coosan Athlone, IE 3 54
Jenkins, Scott Downington, US 55 1328
Liversidge, Gary Westchester, US 69 2095
Rekhi, Gurvinder Singh Suwanee, US 28 872
Stark, Paul Athlone, IE 46 1814

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation